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In supine position, using only OAE phase as an indicator (Figure 2):
• LBNP and VTC appear to be effective CMs, with VTC approximately half as effective as 
LBNP. Retained effectiveness during recovery for both CMs is minimal.
• ITD appears to be negatively effective, but  exhibited a small positive effectiveness during 
recovery, about twice that of LBNP and VTC. 
• During combined CMs, VTC do not enhance LBNP effects and ITD tends to decrease 
effectiveness as compared to single CM. Following multiple CM treatment trials, ITD 
recovery tends to enhance effectiveness (i.e. when ITD was used but discontinued).
OAE data from the VCCM experiment support the use of LBNP and VTC as
countermeasures. VTC as applied was found to be about half as effective
as LBNP.
As anticipated, OAE data in the VCCM experiment failed to show ITD as
countering supine-induced pressure. The ITD-only experiment
demonstrated a counter effect for HDT tension but there are challenges in
interpreting OAE data with ITD; in combination with reports in the
literature, data from both studies suggest that OAE data are affected by
active ITD breathing through an unknown mechanism.
Based on OAE data alone, LBNP is the most effective countermeasure, but
ITD maintains the most effect once the CM is removed (recovery period).
We had anticipated that measurements of MEP in both experiments would
help understand the mechanisms involved in OAE phase changes. LBNP
and VTC cause an unexpected increase in MEP with a paradoxical decrease
in OAE phase shift; ITD does not substantially affect MEP in the VCCM
cohort. These observations add to interpretation difficulty.
Other data from the VCCM study (IJV ultrasound, etc.) are needed to
determine overall CM effectiveness rankings.
In this analysis we use OAE data from two sources: the ITD and VCCM
studies. In the VCCM study (N=10), baseline OAE phase and MEP were
measured in seated and supine positions. Then, in supine position only, LBNP,
ITD, and VTC were applied individually and in combination to investigate the
effects on OAE and MEP. Two subjects’ data were entirely excluded in each
study due to too weak OAE responses and a further 10% of individual
readings (of 670) were excluded due to poor signal to noise ratios, and two
readings which were >2 standard deviations from the mean were excluded.
The ITD-only study (N=15) examined the effect of ITD breathing on OAE
phase and MEP in seated, supine and 3 levels of HDT. Four subjects’ data
where excluded from the ITD due to noise related response delay instability.
Transient evoked otoacoustic emissions (TEOAEs) and ear canal acoustic
stimulus responses were recorded from 600 Hz to 6 kHz, using the Otoport
Advance clinical OAE instrument (Otodynamics Ltd., Hatfield, UK). For each
subject we analysed 2 or 3 frequency bands with highest signal to noise in the
range 0.8-1.8kHz, where most procedure-related changes are seen. OAE
response phases are not corrected for concomitant stimulation phase
changes. MEP measurements were made with a Tympstar middle ear
analyser (Grason-Stadler, Eden Prairie, MN, USA)
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CONCLUSIONS
Spaceflight-associated neuro-ocular syndrome (SANS) is a human
spaceflight risk recognized by NASA. Elevated intracranial pressure
(ICP) has been implicated as a root cause of many SANS signs and
symptoms, yet there is no reliable noninvasive means of monitoring ICP.
We have developed a noninvasive method of monitoring ICP change
that exploits ear canal acoustic and otoacoustic emission (OAE)
measurements. Changed ICP alters pressure in the inner ear, leading to
changes in the tension and position of middle ear (ME) components;
tension of these components determines the phase of the stimulus in
the ear canal and the OAE response sound transmission back through
the ME (Figure 1).
DISCUSSION AND INTERPRETATION
Figure 1: Anatomical
components, with the OAE
probe fitted into the ear canal.
The probe contains a
loudspeaker and a microphone.
The middle ear (ME)
mechanism physically couples
the ear canal to the cochlea via
the stapes. Fluid in the cochlea
is normally in pressure
equilibrium with ICP. Raised ICP
pushes on the stapes,
displacing it and the ME bones,
pushing the ear drum
outwards. This increases elastic
tension in the stapes annular
ligament AND the tympanic
membrane (drum). Tension
increase in turn leads to a
shortening of transmission time
through the ME, seen as a
phase change in the OAE. Inset
is an example of a click evoked
OAE response, showing how
the later, lower frequency
waves arrive earlier under head
down tilt (ICP is higher and
annular ligament more tense).
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Figure 5: Middle ear pressure
(MEP) during experimental
procedures (VCCM
experiment, N=20 ears). MEP
affects ear system tension
which in turn affects OAE
phase shift, and potentially
other ear-based non-invasive
ICP measures such as
cochlear and cerebral
pressure (CCFP) analysis.
Figure 3: Change in otoacoustic emission
(OAE) phase shift as a result of ITD
breathing in multiple postures (ITD
experiment, N=9). 6° and 15° head down
tilt (HDT) and 15° HDT extended (ext;
additional 30 minutes at 15° HDT) were
tested in addition to seated and supine
positions. In this figure the positive
direction indicates a decrease in ME
tension as compared to the same posture
without an active ITD (sham). Note that
for the supine posture, ITD increased ME
tension, whereas ultrasound measures
indicated a decrease in IJV pressure and
cross-sectional area..
LBNP is an active, externally powered countermeasure affecting the entire lower
body from the abdomen downward, inducing large fluid redistribution. Not
surprisingly, this countermeasure also induces large shifts in OAE response phase
(59% relief of supine effect, Figure 2).
VTCs operate on a similar principle of fluid redistribution but are based on passive,
occlusion-mediated sequestration of fluid in the legs below the level of cuff
application. This passive nature and less affected body area could explain why
VTC was only about half as effective as LBNP (34% relief of supine effect, Figure
2). During combined CM application, VTC did not appear to enhance the effect of
LBNP, perhaps because LBNP had already maximized fluid redistribution.
ITD uses negative thoracic pressure induced by resistive breathing in an effort to
reduce cephalic venous congestion, and lower ICP. In both experiments, OAE
phase during ITD breathing was advanced in relation to supine position with no
treatment, indicating a more tense ME, or NEGATIVE effectiveness (VCCM study -
13%, ITD study -51%). Further, during combined CM trials, ITD breathing reduced
the positive effectiveness of other CMs. There are three possible explanations for
the observation of ITD breathing apparently increasing ME tension in supine:
1. ITD breathing actually elevates ICP: This is not likely given that several studies
have reported reduced ICP with negative thoracic pressure breathing
(Convertino 2005, Kiehna 2013). Additionally, the ITD-only study demonstrated
that IJV congestion was reduced with ITD breathing (~18% reduction in IJV
cross sectional area in supine, 6° HDT, and 15° HDT, as well as reduction in IJV
pressure as measured by VeinPress noninvasive methods [18% in supine]).
2. ITD breathing lowers ICP to the point that the oval window (OW) and ME is
being tensioned inward: This is a plausible explanation but unlikely given that
ITD induces 5 mmHg negative thoracic pressure, and average supine ICP is
~15 mmHg.
3. ITD breathing affects the ear by an unknown mechanism, which causes tension
on the OW or tympanum: By process of elimination, this explanation is the most
likely. Additionally, ITD recovery trials (during which ITD was used but
discontinued) are among the most effective recovery periods at reducing ME
tension. This implies that ITD was having intended effects during active ITD
breathing, but the OAE method was not able to capture this due to interference.
OAE phase shift data from the ITD-only experiment (Figure 3) demonstrated an
unexpected pattern of increased ME tension in the supine posture, almost no effect
in 6° HDT, but with a trend toward ME relaxation in 15° HDT. These data suggest a
local tensioning effect of ITD breathing which is overcome at higher angles of HDT.
VCCM data corroborate the tensioning effect in supine. Given that ITD induces
large pressure excursions in the airway, a plausible hypothesis is that these
pressures affect MEP, altering ME tension and OAE phase shift. However, MEP
data do not indicate dramatic alterations during ITD breathing, rather a reduction in
posture-induce pressure (Figures 4 & 5). It is still plausible that the supine position
alters the Eustachian tube and surrounding tissues to make the ME more
susceptible to airway pressure changes, and we do not exclude the possibility of
soft-tissue induced ME tension changes that do not alter MEP.
Interestingly, although LBNP and VTC reduce supine-induced ME tension as
indicated by OAEs (Figure 2), they increase MEP as compared to the supine
posture with no treatment (Figure 5). We have previously argued that the MEP
increase in supine or HDT is a another manifestation of increased ICP, in which
case we would have expected a decrease in MEP due to the application of
effective CMs - consistent with the premise of relieving the supine effect. In this
experiment we observe the opposite effect, which is perplexing. We continue to
analyze these data, including ear canal acoustics (stimulation signals) to
understand this phenomenon.
Figure 2: OAE phase shift was used to determine percent effectiveness ratings of individual and combined countermeasures (VCCM
experiment, N=8). Due to differences in OAE phase on the three test days, OAE phase shift was normalized to the seated position for
each testing day (day 1 for individual CMs; mean of days 2 & 3 for combined CMs). Percent effectiveness was calculated based on
the ability of the treatment to counteract the shift induced by supine position as compared to seated (100*(1-(treatment phase
shift)/(supine phase shift))). Inset: same data plotted in ranked order of effectiveness.
MEP increased in supine and was further increased by LBNP and VTC; ITD did not appear to
have an effect on MEP in the VCCM cohort, but mitigated LBNP- and VTC-induced increases
(Figure 5).
ITD breathing results in posture-dependent effectiveness (Figure 3). Effectiveness is negative
in seated and supine, but becomes positive in 15° HDT.
The OAE method has been validated in several studies, including our
own experiments as part of the NASA Fluid Shifts study. Systematic
OAE phase changes demonstrating increased ME tension (an ICP
indicator) are observed as posture is changed from seated to supine to
head-down tilt (HDT). This effect can be substantially mitigated by lower
body negative pressure (LBNP). The OAE technique has also been
used on International Space Station (ISS) crewmembers, providing
evidence that ICP in microgravity is similar to that seen on the ground in
the supine position.
The OAE method is also a rapid and noninvasive means of assessing
the effectiveness of SANS countermeasures. Here we report results
from two studies which used OAEs. In the most recent study (Venous
Congestion Countermeasures - VCCM), three promising
countermeasures [LBNP, an impedance threshold device (ITD), and
veno-occlusive thigh cuffs (VTC)] were applied individually and in
combination. In our previous ITD-only study, ITD was investigated for
its ability to reduce ICP and cephalic venous congestion in supine and
various HDT postures. Internal jugular vein (IJV) ultrasound showed a
clear decongestive effect at all postures, however OAE data showed
that ITD only caused a phase decrease (tension decrease) in HDT
postures. In supine, ITD appeared to INCREASE tension. This paradox
leads us to hypothesize that the OAE method is not accurately
representing ICP changes with countermeasures (CM), which can alter
ME tension through other means, such as ME pressure (MEP) changes.
More generally, the exact mechanism for observed OAE response and
stimulus phase shifts are not clearly understood, specifically with regard
to the effects of MEP. The VCCM study examined the effects of
externally-applied MEP on OAE recordings to document the relationship
between these parameters. Analysis of these data provide new insights
to these OAE mechanisms, in addition to results on CM effectiveness.
Figure 4: Changes in posture
systematically change measured MEP.
Data from the ITD study (N=29 ears) show
that ITD partially mitigates this effect.
Note that MEP measurements are based
on the externally applied air pressure that
results in maximum ear drum
compliance. Balancing out existing drum
tension does not differentiate between
pneumatic and mechanical forces,
therefore measured MEP might not
indicate actual MEP.
MEP increases with increasing head down tilt (HDT), which is partially mitigated by ITD
(Figure 4)
Phase changes in ear canal stimulus responses from seated to supine were clearly positive 
(as for OAE phase), but were not reduced by LBNP, VTC or ITD. (data not shown)
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